GlassScriptPhysician profile
John P Kirby
NPI 1902829823
$12,033.88
in general payments reported to CMS, 2019-2025
22 companies · $7,612 in 2025
The $7,612 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $877 · 2021: $29.32 · 2022: $1,584 · 2023: $598 · 2024: $1,333 · 2025: $7,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,700 · Consulting Fee: $2,725 · Food and Beverage: $2,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,700.12 |
| Consulting Fee | $2,724.66 |
| Food and Beverage | $2,118.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reprise Biomedical, INC. | $7,430.02 | 2023-2025 | Miro3d |
| Elite Orthopedics, LLC | $1,200.00 | 2022 | |
| Kci USA, INC. | $949.63 | 2019-2023 | V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac, Prevena Restor Arthroform |
| Intuitive Surgical, INC. | $858.63 | 2019-2025 | |
| Kerecis Limited | $320.94 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $266.86 | 2021-2024 | Grafix Pl, Stravix Pl, Oasis |
| Avita Medical Americas, LLC | $261.23 | 2024-2025 | Recell, Cohealyx, Permeaderm |
| Tela Bio, INC. | $120.39 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Organogenesis INC. | $119.60 | 2023 | Puraply Antimicrobial |
| Aroa Biosurgery Incorporated | $112.93 | 2025 | |
| Innovation Technologies INC | $85.82 | 2022 | |
| Trevena, INC. | $78.98 | 2022 | |
| Polarityte, INC. | $54.02 | 2019 | |
| Convatec INC. | $44.42 | 2025 | |
| Hydrofera LLC | $24.24 | 2025 | Hydrofera Blue |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $23.00 | 2025 | Nimbl, Flexitouch Plus |
| Polynovo North America LLC | $22.08 | 2025 | Novosorb Btm |
| Ets Wound Care LLC | $16.05 | 2024 | Mirragen Advanced Wound Matrix |
| Shire North American Group INC | $15.61 | 2019 | |
| Medline Industries LP | $14.81 | 2025 | |
| Acera Surgical, INC. | $14.62 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kirby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.